A study published on March 17, 2026, explores the impact of engineered lipid nanoparticles on mRNA vaccine performance, focusing on their ability to reprogram immune metabolism.
These lipid nanoparticles are integral to the activation of the immune system, which is crucial for the efficacy of mRNA vaccines.
The findings suggest that by enhancing immune responses, these engineered nanoparticles could lead to more effective vaccines with a lower incidence of side effects.